Sunder Biomedical Tech. Co., Ltd. (4115.TWO)
TWD 10.35
(-2.36%)
TWD 10.35
(-2.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 47.41 Million | 104.42 Million | 177.86 Million | 104.74 Million | - |
| Net Income | -40.51 Million | 12.22 Million | 87.77 Million | 59.09 Million | - |
| Depreciation & Amortization | 104.62 Million | 104.49 Million | 96.43 Million | 85.84 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 885 Thousand | 1.13 Million | 1.88 Million | 2.33 Million | - |
| Change in working capital | -14.88 Million | -7.33 Million | 2.08 Million | -33.96 Million | - |
| Other non-cash items | 9.34 Million | 5.38 Million | 4.25 Million | 9.98 Million | - |
| Investing Cash Flow | -101.21 Million | -4.6 Million | -70.97 Million | -174.96 Million | - |
| Investments in PPE | -61.24 Million | -73.84 Million | -94.73 Million | -139.13 Million | - |
| Acquisitions | 801 Thousand | - | - | - | - |
| Investment purchases | -40.76 Million | - | - | - | -1.89 Million |
| Sales/Maturities of investments | - | 48.6 Million | 20.69 Million | -36.07 Million | - |
| Other Investing Activities | -8000.00 | -2.02 Million | 922 Thousand | -2.67 Million | - |
| Financing Cash Flow | 30.51 Million | -94.64 Million | -94.6 Million | 103.22 Million | - |
| Debt repayment | -53.05 Million | -55.48 Million | -72.95 Million | -106.65 Million | - |
| Dividends payments | -18 Million | -36 Million | -18 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -858 Thousand | 577 Thousand | 10 Thousand | - | 1.27 Million |
| Accounts receivables | -10.97 Million | - | - | - | - |
| Accounts payables | -1.91 Million | - | - | - | - |
| Inventory | 4.25 Million | -25.08 Million | 19.58 Million | -33.59 Million | - |
| Other working capital | -8.16 Million | - | - | - | - |
| Cash at beginning of period | 133.62 Million | 127.64 Million | 115.92 Million | 81.81 Million | - |
| Cash at end of period | 108.04 Million | 133.62 Million | 127.64 Million | 115.92 Million | - |
| Capital Expenditure | -61.24 Million | -73.84 Million | -94.73 Million | -139.13 Million | - |
| Effect of forex changes on cash | -2.29 Million | 811 Thousand | -565 Thousand | 1.1 Million | - |
| Net cash flow / Change in cash | -25.57 Million | 5.98 Million | 11.71 Million | 34.11 Million | - |
| Free Cash Flow | -13.83 Million | 30.57 Million | 83.12 Million | -34.39 Million | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.61 Million | -40.51 Million | -2.03 Million | -31.12 Million | -12.84 Million | 12.22 Million |
| Depreciation & Amortization | 41.92 Million | 104.62 Million | 52.44 Million | 52.17 Million | 52.93 Million | 104.49 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 885 Thousand | - | - | - | 1.13 Million |
| Change in working capital | -18.09 Million | -14.88 Million | -22.33 Million | 7.59 Million | 13.19 Million | -7.33 Million |
| Other non-cash items | 112 Thousand | 9.34 Million | -9.17 Million | -5000.00 | 332 Thousand | 5.38 Million |
| Investing Cash Flow | 23.61 Million | -101.21 Million | -51.53 Million | -49.68 Million | -18.1 Million | -4.6 Million |
| Investments in PPE | -43.65 Million | -61.24 Million | -25.44 Million | -34.72 Million | -37.45 Million | -73.84 Million |
| Acquisitions | 54.1 Million | - | 75 Thousand | 726 Thousand | 21.93 Million | - |
| Investment purchases | - | -40.76 Million | -26.45 Million | -14.3 Million | - | - |
| Sales/Maturities of investments | 12.9 Million | - | - | - | 303 Thousand | 48.6 Million |
| Other Investing Activities | 265 Thousand | -8000.00 | 300 Thousand | -308 Thousand | 253 Thousand | -2.02 Million |
| Financing Cash Flow | -98.01 Million | 30.51 Million | 36.31 Million | -5.93 Million | -94.86 Million | -94.64 Million |
| Debt repayment | -97.37 Million | -53.05 Million | -57.38 Million | -4.46 Million | -56.63 Million | -55.48 Million |
| Dividends payments | - | -18 Million | -18 Million | - | -36 Million | -36 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -648 Thousand | -858 Thousand | -3.06 Million | -1.47 Million | -2.22 Million | 577 Thousand |
| Accounts receivables | -14.73 Million | - | -55.97 Million | 45 Million | 16.08 Million | - |
| Accounts payables | -15.37 Million | - | 16.42 Million | -18.34 Million | -12.82 Million | - |
| Inventory | 16 Million | 4.25 Million | 11.29 Million | -7.04 Million | 12.07 Million | -25.08 Million |
| Other working capital | -3.99 Million | - | 5.92 Million | -12.03 Million | -2.14 Million | - |
| Cash at beginning of period | 163.82 Million | 133.62 Million | 145.19 Million | 160.13 Million | 221.08 Million | 127.64 Million |
| Cash at end of period | 92.32 Million | 108.04 Million | 163.82 Million | 145.19 Million | 160.13 Million | 133.62 Million |
| Capital Expenditure | -43.65 Million | -61.24 Million | -25.44 Million | -34.72 Million | -37.45 Million | -73.84 Million |
| Effect of forex changes on cash | - | -2.29 Million | - | - | - | 811 Thousand |
| Net cash flow / Change in cash | -71.49 Million | -25.57 Million | 18.62 Million | -14.93 Million | -60.95 Million | 5.98 Million |
| Free Cash Flow | -99 Thousand | -13.83 Million | -6.54 Million | -6.08 Million | 16.15 Million | 30.57 Million |
9216
DBRG-PI
RPL
AUSC
PTAM
DRETF